生物MNEDR:用于药物重定向的机制引导网络嵌入
Yizhou Zeng1, Lei Wang2, Xueming Liu2
1School of Future Technology, Huazhong University of Science and Technology, Luoyu Road, 430074 Wuhan, China.
Briefings in bioinformatics
|March 9, 2026
概括
通过整合生物医学网络来预测新的治疗用途,BioMNEDR增强了药物重新用途. 这种以机制为导向的方法提高了发现新药与疾病关联的准确性和可解释性.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物重用加速了治疗发现,但目前的方法缺乏多规模机制集成,限制了解释性.
- 现有的计算方法往往无法捕捉复杂的药物疾病关联.
研究的目的:
- 引入BioMNEDR (用于药物重定向的机制引导网络嵌入),这是一个用于增强药物重定向的新框架.
- 通过整合多层次生物医学机制,提高计算药物重定向的准确性和可解释性.
主要方法:
- 生物MNEDR集成了使用生物策划的元路径的异质生物医学网络.
- 它产生了低维嵌入,保留了蛋白质-蛋白质相互作用和功能层次结构.
- 多路径预测使用XGBoost分类器进行集成.
主要成果:
- 生物MNEDR实现了最先进的性能,在AUROC,AUPR,召回和F1得分中表现优于强的基线.
- 该框架在精度和回忆之间保持了平衡的权衡.
- 案例研究表明,成功地重新发现已批准的药物,并优先考虑新的候选药物.
结论:
- 生物MNEDR提供了一个强大的计算框架,通过明确建模多尺度机制来系统地重新使用药物.
- 该方法提高了药物发现中的预测准确性和生物医学解释性.
- 生物MNEDR有助于识别有前途的候选药物,例如阿尔茨海默病的克罗莫格利西克酸.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.6K
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
1.8K
相关概念视频
Drug Discovery: Overview
12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
G Protein-coupled Receptors
18.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.7K
Protein Networks
4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
Targets for Drug Action: Overview
10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K
